Maria Thompson
Maria Thompson
Pharmaceutical innovation doesn’t just happen because a lot of money is thrown at it or the company has been restructured. It requires a setting...
One welcome result of the pharmaceutical innovation crisis is a shift from blockbuster drugs to rare disease drugs. We are doing our own part to...
Pharmaceutical innovation is a broad term that can encompass and affect any step of the drug discovery and development process, so how exactly are...
With the fiscal cliff negotiations over for now, we turn our attention to the patent cliff. A lot of industry watchers and participants often...
Scientist’s Kevin Lustig recently blogged on mendelspod, explaining how the cost of drug development for pharmaceutical companies often leads to...
In our effort to promote research, Scientist sponsored the NYU Gallatin IGEM team. As we’ve seen before, the IGEM competition generates very cool...
We’ve just wrapped up the Tri-State Open Science Challenge, the second that we’ve held. We are proud to announce four winners awarding $16,000...
This past weekend, Scientist co-organized the Lab to Launch workshop with Biotech Acumen and OBR in San Diego, California to motivate and inspire...
Personalized medicine is increasingly becoming a reality, led by the idea that knowing more about genome will help customize the proper treatment...
A big reason why scientists choose to do research is the desire to ultimately improve human health outcomes. Whether exploring how an enzyme...